Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Van Der Meeren, O; Hatherill, M; Nduba, V; Wilkinson, RJ; Muyoyeta, M; Van Brakel, E; Ayles, HM; Henostroza, G; Thienemann, F; Scriba, TJ; +16 more... Diacon, A; Blatner, GL; Demoitié, MA; Tameris, M; Malahleha, M; Innes, JC; Hellström, E; Martinson, N; Singh, T; Akite, EJ; Khatoon Azam, A; Bollaerts, A; Ginsberg, AM; Evans, TG; Gillard, P; Tait, DR; (2018) Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis. The New England journal of medicine. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa1803484

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1056/NEJMoa1803484

Abstract

Share

Download

Filename: Van-Der-Meeren_etal_2018_Phase-2b-Controlled-Trial-of-M72-AS01E-Vaccine-to-Prevent-Tuberculosis.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar